强筋壮骨丸联合Pkp治疗胸椎压缩性骨折临床疗效及安全性分析(1)
[摘要] 目的 探究強筋壮骨丸联合经皮穿刺椎体成形术(Pkp)治疗胸椎压缩性骨折临床疗效及安全性。 方法 该研究方便选取的60例胸椎压缩性骨折患者，均由该院2016年2月—2019年2月收治，采取随机数字表法将所有患者分为两组，对照组患者(30例)采取经皮穿刺椎体成形术治疗，观察组患者(30例)则经皮穿刺椎体成形术联合强筋壮骨丸治疗，对比两组患者治疗前后Oswestry功能障碍指数评分(ODI评分)、疼痛评分(NRS)、并发症情况及治疗满意率。 结果 治疗前对照组患者ODI及NRS评分分别为(37.45±2.35)分、(5.11±0.12)分，治疗后分别为(24.56±1.67)分、(3.01±0.55)分，观察组治疗前ODI评分及NRS评分分别为(37.55±2.30)分、(5.10±0.11)分，治疗后分别为(20.11±2.06)分，(1.67±0.32)分，两组治疗前ODI及NRS评分相近(P>0.05)，各组治疗后ODI及NRS评分改善，观察组ODI及NRS评分优于对照组(P<0.05);观察组患者并发症率(0.00%)低于对照组(16.67%)(χ2=5.454，P=0.020<0.05);观察组患者治疗满意率(100.00%)高于对照组(76.67%)(χ2=7.924，P=0.005<0.05)。 结论 强筋壮骨丸联合经皮穿刺椎体成形术治疗胸椎压缩性骨折临床疗效显著，患者功能恢复好，并发症率低，满意率高，安全性高，值得临床推广以及应用。
[关键词] 胸椎压缩性骨折;强筋壮骨丸;经皮穿刺椎体成形术;功能障碍;并发症
[中图分类号] R687 [文献标识码] A [文章编号] 1674-0742(2019)12(a)-0054-03
[Abstract] Objective To explore the clinical efficacy and safety of Qiangjin Zhuanggu Pill combined with percutaneous vertebroplasty (Pkp) in the treatment of thoracic vertebral compression fracture. Methods Convenient elected 60 patients with thoracic vertebral compression fracture were enrolled in the study.They were treated in the hospital from February 2016 to February 2019.All patients were divided into two groups by random number table. The control group(30 cases) received percutaneous vertebroplasty，while the observation group (30 cases) received percutaneous vertebroplasty combined with Qiangjin Zhuanggu pill. Oswestry's merit was compared between the two groups before and after treatment.Obstacles index score (ODI score)， pain score (NRS)，complications and treatment satisfaction rate. Results Before treatment，theODI and NRS scores of the control group were(37.45±2.35)points， (5.11±0.12)points，respectively after treatment(24.56±1.67)points，(3.01±0.55) points， observation group ODI score before treatment and NRS score(37.55±2.30)points， respectively(5.10±0.11)points，after treatment respectively(20.11±2.06)points，(1.67±0.32)points， the two groups before treatment ODI and NRS score(P>0.05)，similar groups of ODI and NRS score improvement after treatment，observation group of ODI and NRS score is better than that of control group(P<0.05);The complication rate in the observation group(0.00%)was lower than that in the control group(16.67%) (χ2=5.454，P=0.020<0.05).The treatment satisfaction rate of the observation group was higher(100.00%)than that of the control group(76.67%)(χ2=7.924，P=0.005 <0.05). Conclusion Qiangjin Zhuanggu Pill combined with percutaneous vertebroplasty for thoracic vertebral compression fracture has remarkable clinical efficacy，good functional recovery， low complication rate，high satisfaction rate and high safety，which is worthy of clinical promotion and application., http://www.100md.com(林雷雨 王付贵 唐华)
[关键词] 胸椎压缩性骨折;强筋壮骨丸;经皮穿刺椎体成形术;功能障碍;并发症
[中图分类号] R687 [文献标识码] A [文章编号] 1674-0742(2019)12(a)-0054-03
[Abstract] Objective To explore the clinical efficacy and safety of Qiangjin Zhuanggu Pill combined with percutaneous vertebroplasty (Pkp) in the treatment of thoracic vertebral compression fracture. Methods Convenient elected 60 patients with thoracic vertebral compression fracture were enrolled in the study.They were treated in the hospital from February 2016 to February 2019.All patients were divided into two groups by random number table. The control group(30 cases) received percutaneous vertebroplasty，while the observation group (30 cases) received percutaneous vertebroplasty combined with Qiangjin Zhuanggu pill. Oswestry's merit was compared between the two groups before and after treatment.Obstacles index score (ODI score)， pain score (NRS)，complications and treatment satisfaction rate. Results Before treatment，theODI and NRS scores of the control group were(37.45±2.35)points， (5.11±0.12)points，respectively after treatment(24.56±1.67)points，(3.01±0.55) points， observation group ODI score before treatment and NRS score(37.55±2.30)points， respectively(5.10±0.11)points，after treatment respectively(20.11±2.06)points，(1.67±0.32)points， the two groups before treatment ODI and NRS score(P>0.05)，similar groups of ODI and NRS score improvement after treatment，observation group of ODI and NRS score is better than that of control group(P<0.05);The complication rate in the observation group(0.00%)was lower than that in the control group(16.67%) (χ2=5.454，P=0.020<0.05).The treatment satisfaction rate of the observation group was higher(100.00%)than that of the control group(76.67%)(χ2=7.924，P=0.005 <0.05). Conclusion Qiangjin Zhuanggu Pill combined with percutaneous vertebroplasty for thoracic vertebral compression fracture has remarkable clinical efficacy，good functional recovery， low complication rate，high satisfaction rate and high safety，which is worthy of clinical promotion and application., http://www.100md.com(林雷雨 王付贵 唐华)